![Andrew Shales](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Shales
Directeur Général chez
Key Positioning Ltd.
Profil
Andrew D.
Shales is currently the Chief Executive Officer at Key Positioning Ltd. and Resilia Pharmaceuticals, Inc. He previously served as the Chief Operating Officer & Secretary at Multi-Link Telecommunications, Inc. and as the Chief Operating Officer at Auriga Laboratories, Inc. He also held the position of Chief Operating Officer & Secretary at Auriga Laboratories, Inc. from 2006 to 2007.
Shales received his undergraduate degree from King's College (Pennsylvania) in 1986.
Postes actifs de Andrew Shales
| Sociétés | Poste | Début |
|---|---|---|
Key Positioning Ltd. | Directeur Général | - |
Resilia Pharmaceuticals , Inc.
 Resilia Pharmaceuticals , Inc. Pharmaceuticals: MajorHealth Technology Resilia Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on acquiring, licensing, and developing high-value but underpromoted and late-stage therapeutics. The company is based in Atlanta, GA. The company supports patients and healthcare providers by offering FDA-approved products such as Ecoza® (econazole nitrate 1% topical foam), Recedo® (topical gel), Neocera™ (advanced cream), and Neosalus® (advanced cream, foam, or lotion), which are available through retail pharmacies and wholesalers. Resilia Pharmaceuticals provides responsible pricing programs and comprehensive resources for physicians and patients, including prescribing information, savings coupons, and channels for reporting adverse events or product quality concerns. The CEO of the company is Andrew D. Shales. | Directeur Général | - |
Anciens postes connus de Andrew Shales
| Sociétés | Poste | Fin |
|---|---|---|
Auriga Laboratories, Inc.
 Auriga Laboratories, Inc. BiotechnologyHealth Technology Engages in the commercialization, licensing and development of prescription pharmaceutical products | Directeur des opérations | 05/11/2007 |
Multi-Link Telecommunications, Inc.
 Multi-Link Telecommunications, Inc. Wireless TelecommunicationsCommunications Provides integrated voice and fax messaging services for small and medium sized businesses | Directeur des opérations | 21/07/2006 |
Auriga Laboratories, Inc. /Old/
 Auriga Laboratories, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Directeur des opérations | 20/07/2006 |
Formation de Andrew Shales
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
20
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Multi-Link Telecommunications, Inc.
Multi-Link Telecommunications, Inc. Wireless TelecommunicationsCommunications Provides integrated voice and fax messaging services for small and medium sized businesses | Communications |
Auriga Laboratories, Inc. /Old/
Auriga Laboratories, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
King's College (Pennsylvania)
 King's College (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Auriga Laboratories, Inc.
Auriga Laboratories, Inc. BiotechnologyHealth Technology Engages in the commercialization, licensing and development of prescription pharmaceutical products | Health Technology |
Key Positioning Ltd. | |
Resilia Pharmaceuticals , Inc.
Resilia Pharmaceuticals , Inc. Pharmaceuticals: MajorHealth Technology Resilia Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on acquiring, licensing, and developing high-value but underpromoted and late-stage therapeutics. The company is based in Atlanta, GA. The company supports patients and healthcare providers by offering FDA-approved products such as Ecoza® (econazole nitrate 1% topical foam), Recedo® (topical gel), Neocera™ (advanced cream), and Neosalus® (advanced cream, foam, or lotion), which are available through retail pharmacies and wholesalers. Resilia Pharmaceuticals provides responsible pricing programs and comprehensive resources for physicians and patients, including prescribing information, savings coupons, and channels for reporting adverse events or product quality concerns. The CEO of the company is Andrew D. Shales. | Health Technology |
